Status:
COMPLETED
Hepatitis B and HIV Co-Infection in Patients in Uganda
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Hepatitis B
HIV Infections
Eligibility:
All Genders
18-99 years
Brief Summary
This study will determine the amount of liver scarring (fibrosis) or liver damage in people infected with 1) hepatitis B virus (HBV, a virus that can infect the liver); 2) HIV (the virus that causes A...
Detailed Description
While there are around 25 million HIV-infected persons in sub-Saharan Africa, there are also an estimated 50 million with chronic hepatitis B virus (HBV) infection. Yet data from Africa on the prevale...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Willing and able to provide individual informed consent
- Currently being followed at the RHSP or IDI Adult Infectious Disease Clinic
- Persons aged 18 years and older
- EXCLUSION CRITERIA:
- Age less than 18 years
- Women who are pregnant
- Participants with a cardiac device (i.e., pacemaker)
- Participants not willing to allow storage of samples
- Participants not able to follow study instructions
Exclusion
Key Trial Info
Start Date :
October 27 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 14 2018
Estimated Enrollment :
6303 Patients enrolled
Trial Details
Trial ID
NCT00782158
Start Date
October 27 2008
End Date
December 14 2018
Last Update
December 5 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Infectious Diseases Institute
Kampala, Uganda
2
International Ctr for Excellence in Research and Rakai Health Sciences Program
Rakai, Uganda